简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Skye Bioscience Q2 EPS $(0.44) Misses $(0.31) Estimate

2025-08-08 04:45

Skye Bioscience (NASDAQ: SKYE) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.31) by 40.58 percent. This is a 120 percent decrease over losses of $(0.20) per share from the same period last year.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。